Autoimmune Disease Diagnosis Market Introduction & Overview

The function of the immune system is to produce a response intended toward protection against harmful bacteria, parasites, and cancerous cells and to prevent them from invading the body. Autoimmune diseases result in the body’s own immune system attacking body parts including joints, skin, pancreas, and other organs. There are more than 80 types of autoimmune diseases that affect different body parts. Some of the common examples include rheumatoid arthritis, psoriasis/psoriatic arthritis, multiple sclerosis, type 1 diabetes, and others.

The rising number of people having autoimmune disorders, increasing access to medical insurance, increasing adoption of routine laboratory tests for a variety of diseases, an increasing number of awareness programs for autoimmune diseases and technological advancements ensuring better autoimmune diagnosis are some of the pivotal factors contributing to market growth. However, high capital requirements for the development of the diagnostic tests will restrict market growth.

The global autoimmune disease diagnosis market is segmented into product & services, test type, disease, end user and region.

Autoimmune Disease Diagnosis Market By Product & Services

Based on products & services, the market can be segmented into consumables & assay kits, instruments, and services. The consumables & assay kits segment holds the largest market share owing to the increasing prevalence of autoimmune diseases and the growing number of hospitals & clinics using consumables & assay kits for diagnostic purposes.

Autoimmune Disease Diagnosis Market By Test Type

Based on test type the market can be classified into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and others. The routine laboratory tests segment holds the largest market share owing to the increase in the adoption of routine laboratory tests for the diagnosis of different chronic diseases among the population.

Autoimmune Disease Diagnosis Market By Disease Indication

Based on the disease indication, the market can be classified into rheumatoid arthritis, Systemic Lupus Erythematosus (SLE), sjögren’s syndrome, thyroiditis, scleroderma, and others. The rheumatoid arthritis segment dominates the market owing to its rising incidences globally. According to the WHO, there are approximately 3 cases of rheumatoid arthritis per 10,000 people with a prevalence rate of approximately 1%, and it is increasing with age.

Autoimmune Disease Diagnosis Market By End User

Based on end user, the market can be segmented into clinical laboratories, hospitals, and others. The clinical laboratories segment holds the largest market share owing to an increase in a number of clinical laboratories with autoimmune disease diagnostics for diagnosing and treating the diseases. The availability of advanced diagnostic equipment at clinical laboratories further propels market growth.

Autoimmune Disease Diagnosis Market By Region

Based on region, the market can be segmented into four regions – North America, Europe, Asia-Pacific, and the Rest of the World (ROW). North America will hold the largest market share during the forecast period. Factors attributing to the growth of this region include the growing number of autoimmune disease cases, better accessibility to advanced technologies, opportunities for advanced autoimmune diagnostic testing & screening, rising investments in the field of autoimmune disease diagnosis and improving government support & initiatives to assist technological advancements & developments in this sector. Autoimmune diseases are among the most prevalent diseases in the U.S. and according to the American Autoimmune Related Diseases Association (AARDA). It has been estimated that 50 million Americans suffer from autoimmune diseases.

Autoimmune Disease Diagnosis Market Prominent Players

Some of the key players operating in the global autoimmune disease diagnosis market include Siemens AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Hemagen Diagnostics, Inc., Bio-Rad Laboratories, Inc., GRIFOLS, S.A., Trinity Biotech Plc., Inova Diagnostics, Inc., HYCOR Biomedical, EUROIMMUN AG, and others.